|
Apellis Pharma raises $17.6M; focuses on asthma and COPD
MedCity News But the company's site says it is approaching chronic inflammatory diseases like asthma and chronic obstructive pulmonary disease by modifying them rather than suppressing systems. Waiting on a call back from COO Pascal Deschatelets to discuss the … |
View full post on asthma – Google News